EUVIMEDEUVIMED entdecken
Fallbericht

SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib

Chen Ru, Tangliang Qian, Xiaoping Liu, Chaoxin Wang, Weizhong Li, Xiujuan Hou iD, Chen Li iD

International Journal of Rheumatic Diseases · 2023

DOI: 10.1111/1756-185x.14628 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Rheumatic Diseases, 2023. Verfasst von Chen Ru und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Acquired Hyperostosis Syndrome, Takayasu Arteritis, Osteitis, Hyperostosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Natural Science Foundation of China(No.82074246), the construction project of a critical clinical specialty in the Fengtai district of Beijing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SAPHO syndrome is an autoinflammatory disease with a variety of clinical manifestations, which may be accompanied by other systemic inflammatory diseases in addition to the typical manifestations of common synovitis, acne, pustulosis, hyperostosis, and osteitis. Here, we report the first case of SAPHO syndrome combined with Takayasu arteritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acquired Hyperostosis SyndromeTakayasu ArteritisOsteitisHyperostosisSynovitisAcne VulgarisHumansPiperidinesPyrimidines

Stichwörter der Autor:innen

SAPHO syndromeTakayasu arteritistofacitinib

Substanzen

tofacitinibPiperidinesPyrimidines

Autor:innen und Institutionen

  • Beijing University of Chinese Medicine, Beijing, China.
  • Department of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
  • Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.

ORCID-Profile: Xiujuan Hou, Chen Li

Förderung

  • National Natural Science Foundation of China(No.82074246)
  • the construction project of a critical clinical specialty in the Fengtai district of Beijing

Zitieren

APA

Ru, C., Qian, T., Liu, X., Wang, C., Li, W., Hou, X., & Li, C. (2023). SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.14628

Vancouver

Ru C, Qian T, Liu X, Wang C, Li W, Hou X, et al. SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib. International Journal of Rheumatic Diseases. 2023. doi:10.1111/1756-185x.14628

BibTeX
@article{Ru2023,
  author = {Ru, Chen and Qian, Tangliang and Liu, Xiaoping and Wang, Chaoxin and Li, Weizhong and Hou, Xiujuan and Li, Chen},
  title = {SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib},
  journal = {International Journal of Rheumatic Diseases},
  year = {2023},
  doi = {10.1111/1756-185x.14628}
}
Kostenlos starten →